Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1993-8-26
|
pubmed:abstractText |
Research and development in nuclear cardiology have made major contributions to the noninvasive approach for detection of coronary artery disease, to the assessment of disease extent and severity, and for prognostication of cardiac events. This article discusses the use of myocardial perfusion imaging and describes techniques for the evaluation of myocardial viability.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0033-8389
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
795-815
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:8337368-Coronary Circulation,
pubmed-meshheading:8337368-Coronary Disease,
pubmed-meshheading:8337368-Coronary Vessels,
pubmed-meshheading:8337368-Humans,
pubmed-meshheading:8337368-Organotechnetium Compounds,
pubmed-meshheading:8337368-Oximes,
pubmed-meshheading:8337368-Technetium Tc 99m Sestamibi
|
pubmed:year |
1993
|
pubmed:articleTitle |
Myocardial perfusion imaging using technetium-99m radiopharmaceuticals.
|
pubmed:affiliation |
Department of Imaging, Cedars-Sinai Medical Center, Los Angeles, California.
|
pubmed:publicationType |
Journal Article,
Review
|